The Pharmacy Times® Insights video library presents one-on-one interviews with pharmacy experts, who examine the latest patient counseling tools and innovative solutions for the everyday practice and business.
What can we help you find?
Considerations for transitioning patients from heparin over to a direct oral anticoagulant for venous thromboembolism prophylaxis, and strategies that can help health care professionals better manage patients through a drug shortage.
Implications for treating appropriate patients with a direct oral anticoagulant, such as rivaroxaban, based on more recent trial data and a new indication for the prevention of venous thromboembolism.
Dr. Manesh R. Patel and Sarah A. Spinler compare and contrast the direct oral anticoagulants betrixaban and rivaroxaban and remark on variables that impact treatment selection.
Patient factors that can help healthcare professionals determine the appropriateness for administering a direct oral anticoagulant versus heparin for prophylaxis of venous thromboembolism.
In this series, Bhavesh Shah, RPh, BCOP and Dr. Katharine Lin, PharmD, BCOP provide an in-depth understanding of chemo-induced nausea & vomiting (CINV) and share some common practices for patient management.
Dr. Manesh R. Patel and Sarah A. Spinler react to the recent shortage of heparin in the United States and consider how the approval of direct oral anticoagulants can potentially serve as an alternative for appropriate patients.
Considerations for managing inventory levels in the pharmacy when navigating through drug shortages.
Sarah A. Spinler highlights common factors that are responsible for drug shortages in the United States and points out available resources that can help educate stakeholders on current drug shortages.
The key opinion leader discusses the patient education needed and how pharmacists can improve their knowledge.
Christopher Altman, PharmD, provides an understanding of the in-home drug testing.
Key opinion leader provides specifics for using the hair drug-testing product with the pros and cons.
Harshav Raval, PharmD, RPh, details the specifics involved with using the urine drug-testing products.